Zhejiang Shengda Bio-Pharm Co., Ltd. (603079.SH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenCNY 12.65

From 52W high−42.56%

Volume3.74M

Market capCNY 2.39B

P/E (TTM)38.4x

P/S (TTM)2.9x

Div yield0.78%

Key dataSep 18, 2026

Open

CNY 12.65

From 52W high

−42.56%

Volume

3.74M

Market cap

CNY 2.39B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

13.7x

P/E (TTM)

38.4x

RSI (14)

50.2

MomentumView details →

1D Return

−9.98%

YTD Return

−27.77%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

38.4x

EV/EBITDA

13.7x

EV/Sales

2.7x

P/S (TTM)

2.9x

P/B (TTM)

1.5x

ProfitabilityView details →

Gross Margin

25.81%

Net Margin

6.46%

EBITDA Margin

19.46%

ROE (TTM)

3.36%

ROA (TTM)

2.45%

Asset Turnover

0.38x

GrowthView details →

Revenue YoY

−1.81%

EPS YoY

+6.35%

FCF YoY

+149.75%

Revenue CAGR 3Y

+4.60%

EPS CAGR 3Y

+24.81%

EBITDA YoY

—

MomentumView details →

1D Return

−9.98%

YTD Return

−27.77%

1Y Return

−28.41%

RSI (14)

50.2

vs 50D SMA

+4.54%

vs 200D SMA

−17.58%

Capital & dividendView details →

Debt/Equity

0.21x

Current Ratio

4.69x

Quick Ratio

3.64x

Div Yield

0.78%

Div Rate

CNY 0.10

Div Growth 1Y

+66.67%

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

830.53M

Net Income (TTM)

53.62M

Op. CF (TTM)

156.78M

Latest newsMore news →

Shengda Bio appointed Lin Weiyuan as board secretary and Mi Yexuan as securities affairs representative on July 6, 2026.75d ago

Similar companies

HUTCHMED (China) LimitedHCM Hua Medicine (Shanghai) Ltd.02552.HK Supernus Pharmaceuticals, Inc.SUPN Chia Tai Enterprises International Limited03839.HK Bausch Health Companies Inc.BHC Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.01349.HK Find similar companies →

Latest newsMore news →

Shengda Bio appointed Lin Weiyuan as board secretary and Mi Yexuan as securities affairs representative on July 6, 2026.75d ago